PRESS RELEASE 1 8 October 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has completed the submission of all information previously requested by the U.S. Food and Drug Administration (FDA) regarding  its c hemistry,

PRESS RELEASE 6 October 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual investor conferences this fall. Details are as follows: Aktiespararna’s Aktiedagen Stockholm 2021 Date/Time: 11

PRESS RELEASE 1 6 September 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Robert E. Hoffman to its board of directors, as resolved at the extraordinary shareholders’ meeting held on September 16, 2021 .